| Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study |
95 |
| Succinate dehydrogenase (SDH)-deficient neoplasia |
32 |
| Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics |
28 |
| Variants and new entities of bladder cancer |
21 |
| PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome |
21 |
| Staging of bladder cancer |
20 |
| New and emerging renal entities: a perspective post-WHO 2016 classification |
19 |
| Defining clinically significant prostate cancer on the basis of pathological findings |
19 |
| Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance |
19 |
| Pathology and genetics of phaeochromocytoma and paraganglioma |
19 |
| Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases |
19 |
| Grading of renal cell carcinoma |
18 |
| Malignant mesothelioma in situ |
15 |
| Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma |
14 |
| Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance |
14 |
| Special types of thyroid carcinoma |
13 |
| Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer |
13 |
| Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells |
13 |
| Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration |
12 |
| The immune microenvironment and expression of PD-L PD- PRAME and MHC I in salivary duct carcinoma |
12 |
| Renal cell carcinoma staging: pitfalls, challenges, and updates |
12 |
| Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion |
11 |
| Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system |
11 |
| Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria |
11 |
| Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis |
11 |
| Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer |
11 |
| Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses |
10 |
| Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells |
10 |
| Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers |
10 |
| Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing |
10 |
| Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis |
10 |
| Basal-subtype bladder tumours show a hot' immunophenotype |
10 |
| Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management |
10 |
| Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set |
9 |
| HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues |
9 |
| Non-urothelial carcinomas of the bladder |
9 |
| PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities |
9 |
| Grading of prostate cancer: a work in progress |
9 |
| Hereditary and familial thyroid tumours |
9 |
| TERT promoter mutations in solitary fibrous tumour |
9 |
| PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy |
9 |
| Comparison of published risk models for prediction of outcome in patients with extrameningeal solitary fibrous tumour |
9 |
| A decreased peritumoral CD1a+cell number predicts a worse prognosis in oral squamous cell carcinoma |
9 |
| Being fully digital: perspective of a Dutch academic pathology laboratory |
9 |
| Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas |
9 |
| Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association |
8 |
| Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma |
8 |
| The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma |
8 |
| The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact |
8 |
| Comparison of Epstein-Barr virus-positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan |
8 |
